INNOTEST® NPTX2
INNOTEST NPTX2 is a solid-phase enzyme immunoassay for the quantitative determination of neuronal pentraxin-2 (NPTX2) in human cerebrospinal fluid (CSF).
Product number 80908
Product number 80909
Click here to navigate
- Contact sales for information
- Details
- Conditions of sale
- Citations
- Documentation
- Insights
- Product inquiry
- Related products
-
Details
This assay should be used in combination with the NPTX2 CAL-RVC pack, article no. 80909 (RUO), of the corresponding lot.
Test principle
The INNOTEST NPTX2 is a solid-phase enzyme immunoassay in which the neuronal pentraxin-2 protein is captured by a first monoclonal antibody, 33F9 (ADx409; IgG1). CSF samples are added and incubated with a biotinylated antibody, 22H10 (ADx410; IgG2a). This antigen-antibody complex is then detected by a peroxidase-labeled streptavidin. After addition of substrate working solution, samples will develop a color. The color intensity is a measure for the amount of human neuronal pentraxin-2 protein in the sample1,2.
Test principle INNOTEST NPTX2 (SV= streptavidin; HRP= horseradish peroxidase).
BackgroundNeuronal pentraxin-2 is a synaptic protein that consistently shows decreased CSF concentrations in Alzheimer’s disease compared to control subjects1,2. Preliminary studies indicate that while CSF NPTX2 correlates poorly with the core CSF biomarkers (β-amyloid and tau) and other synaptic markers, it seems to correlate well with cognitive decline2.
References
- Jacobs D, et al. A monoclonal antibody based immunoassay for Neuronal Pentraxin2 in CSF. ADPD 2019.
- Vanmechelen E, et al. NPTX2 levels in CSF as potential predictor of cognitive dysfunction in the AD continuum. AAIC 2019.
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Citations
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all product documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
Feb 20, 2024Publication - Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients
We would like to draw your attention to a first publication on our Lumipulse® G NfL solution. In this article you will find a method comparison of CSF...
Dec 1, 2023CTAD 2023 – Spotlight on recent advances in blood-based biomarkers for Alzheimer’s disease
Both fluid and imaging biomarkers provide biological evidence for the underlying etiology of cognitive impairment. The core fluid biomarkers of...
Jul 10, 2023IVDR status update for Fujirebio’s Neuro products
The European CE-marking is used to support registrations of in vitro diagnostic (IVD) medical devices in many jurisdictions around the world. The...
-
Product inquiry
-
Related products